Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial-Reference-Cited by-同舟云学术

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Published:2014-09 Issue:9948 Volume:384 Page:1109-1117
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Robert Caroline,Ribas Antoni,Wolchok Jedd D,Hodi F Stephen,Hamid Omid,Kefford Richard,Weber Jeffrey S,Joshua Anthony M,Hwu Wen-Jen,Gangadhar Tara C,Patnaik Amita,Dronca Roxana,Zarour Hassane,Joseph Richard W,Boasberg Peter,Chmielowski Bartosz,Mateus Christine,Postow Michael A,Gergich Kevin,Elassaiss-Schaap Jeroen,Li Xiaoyun Nicole,Iannone Robert,Ebbinghaus Scot W,Kang S Peter,Daud Adil

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

3. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N Engl J Med,2012

4. Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study;McArthur;Lancet Oncol,2014

5. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;N Engl J Med,2012

Cited by 1585 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity;International Immunopharmacology;2024-12

2. Assessment of the level of PD-L1 protein expression on gastric cancer material using the new clone PBM-1A4 and comparison with clones 22C3, SP142, SP263;Morphology;2024-09-04

3. IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma;Molecular Therapy - Nucleic Acids;2024-09

4. Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives;Biomedicines;2024-08-05

5. Immune responses and immunotherapeutic approaches in the treatment against cancer;Clinical & Experimental Metastasis;2024-08